Olink

Olink®
Part of Thermo Fisher Scientific

The influence of metformin treatment on the circulating proteome

eBioMedicine, 2025

Connolly B., McCreight L., Slieker R., Bedair K., Donnelly L., de Klerk J., Beulens J., Elders P., Bergström G., Hong M., Koivula R., Franks P., Schwenk J., Gummesson A., Pearson E., ‘t Hart L., Abdalla M., Adam J., Adamski J., Adragni K., Allesøe R., Allin K., Artati A., Arumugam M., Atabaki Pasdar N., Baltauss T., Banasik K., Barnett A., Baum P., Bell J., Bianzano S., Bizzotto R., Bonnefond A., Brorsson C., Brown A., Brunak S., Cabrelli L., Caiazzo R., Cederberg H., Chabanova E., Clos-Garcia M., Dale M., Davtian D., Dawed A., De Masi F., de Preville N., Dekkers K., Deshmukh H., Dings C., Dutta A., Ehrhardt B., Engelbrechtsen L., Eriksen R., Fan Y., Fernandez J., Ferrer J., Fitipaldi H., Forgie I., Forman A., Frau F., Froguel P., Frost G., Gassenhuber J., Giordano G., Giorgino T., Gough S., Grallert H., Grempler R., Groeneveld L., Groop L., Gudmundsdóttir V., Gupta R., Haid M., Hansen T., Hansen T., Hattersley A., Haussler R., Heggie A., Hennige A., Hill A., Holl R., Hudson M., Jablonka B., Jacobsen U., Jennison C., Johansen J., Jones A., Karaderi T., Kaye J., Kennedy G., Klintenberg M., Koivula R., Kokkola T., Koopman A., Kurbasic A., Kuulasmaa T., Laakso M., Lehr T., Loftus H., Lundgaard A., Lyu L., Mahajan A., Mari A., Mazzoni G., McCarthy M., McDonald T., McEvoy D., McRobert N., McVittie I., Mourby M., Musholt P., Mutie P., Nice R., Nicolay C., Nijpels G., Nilsson B., Palmer C., Pattou F., Pavo I., Pedersen H., Pedersen O., Perry M., Pomares-Millan H., Prehn C., Ramisch A., Rasmussen S., Raverdi V., Ridderstråle M., Robertson N., Rodriquez M., Ruetten H., Rutters F., Sackett P., Scherer N., Shah N., Sharma S., Sihinevich I., Sondertoft N., Staerfeldt H., Steckel-Hamann B., Teare H., Thomas C., Thomas E., Thomas M., Thomsen H., Thorand B., Thorne C., Tillner J., Tsirigos K., Tura A., Uhlen M., van Oort S., Vangipurapu J., Verkindt H., Vestergaard H., Viñuela A., Vogt J., Wad Sackett P., Walker M., Wesolowska-Andersen A., Whitcher B., White M., Efanov A., Giordano G., Bouland G., Burdet F., Dragan I., Festa A., Hansen M., Kuznetsov D., Mehl F., Marek D., Pavo I., Duffin K., Syed S., Shaw J., Cabrera O., Pullen T., Thorens B., Ibberson M., Rutter G.

Disease areaApplication areaSample typeProducts
Metabolic Diseases
Pathophysiology
Plasma
Olink Target 96

Olink Target 96

Abstract

Background
Metformin is one of the most used drugs worldwide. Given the increasing use of proteomics in trials, bioresources, and clinics, it is crucial to understand the influence of metformin on the levels of the circulating proteome.
Methods
We analysed a combined longitudinal proteomics dataset from the IMPOCT, RAMP and S3WP-T2D clinical trials in 98 participants before and after metformin exposure. This discovery analysis contained 372 proteins measured by proximity extension assays (Olink). We followed up experiment–wise statistically significant findings in two cross-sectional cohorts of people with type 2 diabetes comparing metformin treated and untreated individuals: IMI-DIRECT (784 participants, 372 proteins, Olink) and IMI-RHAPSODY (1175 participants, 1195 proteins, SomaLogic).
Findings
Overall, 23 protein analytes were robustly associated with exposure to metformin in the discovery and replication. This includes 11 protein-metformin associations that replicated in both replication sets and platforms (REG4, GDF15, REG1A, t-PA, TFF3, CDH5, CNTN1, OMD, NOTCH3, THBS4 and CD93), with the remaining 12 protein-metformin associations replicated using the Olink platform (EPCAM, SPINK1, SAA-4, COMP, ITGB2, ADGRG2, FAM3C, MERTK, COL1A1, HAOX1, VCAN, TIMD4) but not measured on the SomaLogic platform. Gene-set enrichment analysis revealed that the metformin exposure was associated with intestinal associated proteins.
Interpretation
These data highlight the need to account for exposure to metformin, and potentially other drugs, in proteomic studies and where protein biomarkers are used for clinical care.

Read publication ↗